Bioprocessing Technology Market Insights Highlight Segment Expansion And Market Leadership

The bioprocessing technology sector is gearing up for significant expansion as demand surges across various biopharmaceutical and bioproduct applications. Advancements in automation, process optimization, and novel production methods are setting the stage for a robust market trajectory through the end of the decade. Here is a detailed look at the market size, key players, trends, and segmentation shaping this evolving industry.

Anticipated Market Growth and Size of the Bioprocessing Technology Market
The bioprocessing technology market is poised for rapid growth, expected to reach a value of $139.77 billion by 2030. This corresponds to a strong compound annual growth rate (CAGR) of 14.5%. Factors driving this expansion include the rising demand for biosimilars and recombinant proteins, greater adoption of automation technologies in biomanufacturing, and the growing production of personalized medicines. The market is also benefiting from increased process optimization efforts and more frequent outsourcing to Contract Manufacturing Organizations (CMOs). Key trends anticipated to influence the market going forward include broader use of single-use bioprocessing systems, automated platforms for cell expansion, advanced biologics safety testing integration, continuous bioprocessing techniques, and a stronger emphasis on scalable manufacturing practices.

Download a free sample of the bioprocessing technology market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29261&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Driving the Bioprocessing Technology Market
Several prominent corporations dominate the bioprocessing technology landscape. Notable players include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG, GE Healthcare, Waters Corporation, STADA Arzneimittel AG, Bio-Rad Laboratories Inc., Applikon Biotechnology B.V., Agilent Technologies Inc., Solida Biotech GmbH, Fujifilm Healthcare Corporation, Catalent Inc., Asahi Kasei Medical Inc., Amgen Inc., Eppendorf AG, Repligen Corporation, Becton dic*kinson and Company, MilliporeSigma, Novasep, Boehringer Ingelheim GmbH, Cytiva AB, Wuxi Biologics, AGC Biologics, Samsung Biologics, AbbVie Inc., Bristol Myers Squibb Company, Pfizer Inc., and Roche Holding AG. These companies are influential in shaping the innovation and commercialization landscape within the sector.

Recent Expansion Moves Highlighted by Merck KGaA
Merck KGaA is expanding its footprint in viral vector bioprocessing through the acquisition of Mirus Bio. This strategic move supports Merck's efforts to enhance its capabilities and product portfolio in viral vector production, which is a critical component in gene therapy and vaccine development.

View the full bioprocessing technology market report:
https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends and Opportunities in Bioprocessing Technology
Top players in the market are focusing on developing comprehensive bioprocessing platforms to meet increasing demands for higher yield and efficiency. A bioprocessing platform typically consists of integrated technologies and methods designed for the efficient, large-scale processing of biological materials to manufacture biopharmaceuticals or other bio-based products. For instance, in October 2023, WuXi Biologics introduced WuXiUI, an advanced bioprocessing platform aimed at boosting productivity and quality across various mammalian cell lines and product types. WuXiUI employs an ultra-intensified intermittent-perfusion fed-batch (UI-IPFB) approach, delivering a 3 to 6 times productivity increase compared to traditional fed-batch methods. This innovation addresses critical industry needs such as yield improvement, cost reduction, and compliance with environmental, social, and governance (ESG) standards.

Breakdown of Market Segments within the Bioprocessing Technology Industry
The bioprocessing technology market is divided into key segments based on product type, application, and end-use sectors:
1) By Product: including Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, and Tangential Flow Filtration.
2) By Application: covering Antibiotics, Biosimilars, Recombinant Proteins, and other applications.
3) By End Use: comprising Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Academic Research Institutes, Food and Feed Industry, and Contract Research Organizations (CROs).

Further detailed subcategories include:
- Biologics Safety Testing: Endotoxin Testing, Sterility Testing, Viral Safety Testing
- Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
- Cell Expansion: Manual and Automated Cell Expansion
- Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
- Flow Cytometry: Cell Sorting, Cell Analysis
- Tangential Flow Filtration: Microfiltration, Ultrafiltration

These segments enable a deeper understanding of specific technologies and applications driving market demand and innovation.

Our 2026 market reports now include enhanced strategic insights through:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.